Journal
CURRENT MOLECULAR MEDICINE
Volume 15, Issue 5, Pages 456-461Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1566524015666150630124649
Keywords
Systemic lupus erythematosus; autoantibody profiling; proteomic microarray; biomarker; high-throughput assay
Categories
Ask authors/readers for more resources
Systemic lupus erythematosus (SLE) is a chronic autoimmune connective tissue disease characterized by the production of a large number of autoantibodies, but the etiology is complex and poorly understood. A range of different platforms have served as screening methods for the determination of autoantibody specificities over the past few decades. Proteomic microarray is a relatively new high-throughput technology which is playing an increasingly important role in autoantibody diagnostics. In this article, we review different platforms for assaying autoantibodies in SLE, and highlight the use of autoantigen arrays as powerful tools for autoantibody exploration in SLE.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available